These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23998076)

  • 1. Tackling the problems of tumour chemotherapy by optimal drug scheduling.
    Remesh A
    J Clin Diagn Res; 2013 Jul; 7(7):1404-7. PubMed ID: 23998076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of drug scheduling for cancer chemotherapy with considering reducing cumulative drug toxicity.
    Liu P; Xiao Q; Zhai S; Qu H; Guo F; Deng J
    Heliyon; 2023 Jun; 9(6):e17297. PubMed ID: 37484317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing an efficient scheduling template of a chemotherapy treatment unit: A case study.
    Ahmed Z; Elmekkawy T; Bates S
    Australas Med J; 2011; 4(10):575-88. PubMed ID: 23386870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic optimisation of cancer chemotherapy. Effect on outcomes.
    Masson E; Zamboni WC
    Clin Pharmacokinet; 1997 Apr; 32(4):324-43. PubMed ID: 9113440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive control methods for the dose individualisation of anticancer agents.
    Rousseau A; Marquet P; Debord J; Sabot C; Lachâtre G
    Clin Pharmacokinet; 2000 Apr; 38(4):315-53. PubMed ID: 10803455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automating the drug scheduling of cancer chemotherapy via evolutionary computation.
    Tan KC; Khor EF; Cai J; Heng CM; Lee TH
    Artif Intell Med; 2002 Jun; 25(2):169-85. PubMed ID: 12031605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis and chemotherapy resistance: optimizing chemotherapy scheduling using mathematical modeling.
    Bodzioch M; Bajger P; Foryś U
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2281-2299. PubMed ID: 34050795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-objective optimal chemotherapy control model for cancer treatment.
    Algoul S; Alam MS; Hossain MA; Majumder MA
    Med Biol Eng Comput; 2011 Jan; 49(1):51-65. PubMed ID: 20886373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose topotecan with granulocyte-colony stimulating factor in fluoropyrimidine-refractory colorectal cancer: a phase II and pharmacodynamic study.
    Rowinsky EK; Baker SD; Burks K; O'Reilly S; Donehower RC; Grochow LB
    Ann Oncol; 1998 Feb; 9(2):173-80. PubMed ID: 9553662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic/pharmacodynamic modeling of combination-chemotherapy for lung cancer.
    Curtis LT; van Berkel VH; Frieboes HB
    J Theor Biol; 2018 Jul; 448():38-52. PubMed ID: 29614265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.
    Sandhu SK; Schelman WR; Wilding G; Moreno V; Baird RD; Miranda S; Hylands L; Riisnaes R; Forster M; Omlin A; Kreischer N; Thway K; Gevensleben H; Sun L; Loughney J; Chatterjee M; Toniatti C; Carpenter CL; Iannone R; Kaye SB; de Bono JS; Wenham RM
    Lancet Oncol; 2013 Aug; 14(9):882-92. PubMed ID: 23810788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil dynamics during concurrent chemotherapy and G-CSF administration: Mathematical modelling guides dose optimisation to minimise neutropenia.
    Craig M; Humphries AR; Nekka F; Bélair J; Li J; Mackey MC
    J Theor Biol; 2015 Nov; 385():77-89. PubMed ID: 26343861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.
    Stockmann C; Constance JE; Roberts JK; Olson J; Doby EH; Ampofo K; Stiers J; Spigarelli MG; Sherwin CM
    Clin Pharmacokinet; 2014 May; 53(5):429-54. PubMed ID: 24595533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for different chemotherapeutic and radiation therapy strategies in cancer management.
    Looney WB; Hopkins HA
    Cancer; 1991 Mar; 67(6):1471-83. PubMed ID: 2001534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer: a phase 1b study.
    Czito BG; Deming DA; Jameson GS; Mulcahy MF; Vaghefi H; Dudley MW; Holen KD; DeLuca A; Mittapalli RK; Munasinghe W; He L; Zalcberg JR; Ngan SY; Komarnitsky P; Michael M
    Lancet Gastroenterol Hepatol; 2017 Jun; 2(6):418-426. PubMed ID: 28497757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
    Cvetkovic RS; Goa KL
    Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intercalated erlotinib-docetaxel dosing schedules designed to achieve pharmacodynamic separation: results of a phase I/II trial.
    Sangha R; Davies AM; Lara PN; Mack PC; Beckett LA; Hesketh PJ; Lau D; Li T; Perkins N; Gandara DR
    J Thorac Oncol; 2011 Dec; 6(12):2112-9. PubMed ID: 21892109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.